InMed Pharmaceuticals | Benzinga Cannabis Capital Conference

InMed Pharmaceuticals

NASDAQ: INM

InMed Pharmaceuticals is a leader in the manufacturing and development of rare cannabinoids. InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates and is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. InMed is also developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids and recently announced a definitive agreement to acquire BayMedica, a leader in the commercialization and manufacture of rare cannabinoids.

Get Your Tickets Now!

To enter a promo code, please click the "Enter promo code" link below.

Traffic Roots Audience Pixel